Millennium Management
AVIR icon

Millennium Management’s Atea Pharmaceuticals AVIR Stock Holding History

Millennium Management’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.88M Sell
349,932
-348,224
-50% -$1.6M ﹤0.01% 3922
2025
Q4 		$2.49M Buy
698,156
+210,933
+43% +$670K ﹤0.01% 3745
2025
Q3 		$1.41M Buy
487,223
+312,733
+179% +$1.07M ﹤0.01% 4349
2025
Q2 		$628K Buy
174,490
+97,928
+128% +$292K ﹤0.01% 4740
2025
Q1 		$229K Buy
76,562
+54,056
+240% +$169K ﹤0.01% 5240
2024
Q4 		$75.4K Buy
+22,506
New +$74.8K ﹤0.01% 5527
2024
Q2 		– Sell
-212,763
Closed -$860K – 5869
2024
Q1 		$860K Buy
212,763
+197,163
+1,264% +$772K ﹤0.01% 4428
2023
Q4 		$47.6K Sell
15,600
-27,784
-64% -$84.1K ﹤0.01% 5483
2023
Q3 		$130K Sell
43,384
-24,406
-36% -$83K ﹤0.01% 5266
2023
Q2 		$254K Sell
67,790
-4,868
-7% -$18.2K ﹤0.01% 4998
2023
Q1 		$243K Sell
72,658
-107,028
-60% -$434K ﹤0.01% 5055
2022
Q4 		$864K Buy
+179,686
New +$909K ﹤0.01% 4304
2021
Q4 		– Sell
-115,671
Closed -$4.05M – 6769
2021
Q3 		$4.05M Buy
+115,671
New +$3.21M ﹤0.01% 3117
2021
Q2 		– Sell
-32,420
Closed -$2M – 6510
2021
Q1 		$2M Buy
+32,420
New +$2.19M ﹤0.01% 3533

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management's AVIR Position: Q1 2026 in Review

Millennium Management reduced its Atea Pharmaceuticals (AVIR) stake by 50% in Q1 2026, selling an estimated $1.6M and leaving 349,932 shares worth $1.88M. The position accounts for ﹤0.01% of the portfolio, ranked #3922.

Millennium Management first reported a position in AVIR in Q1 2021 and has held it in 14 quarters since. The position peaked at $4.05M in Q3 2021. 127 funds tracked by Wall St. Rank hold AVIR as of Q1 2026.

  • Millennium Management held 349,932 shares of Atea Pharmaceuticals worth $1.88M as of Q1 2026.
  • Millennium Management sold 348,224 Atea Pharmaceuticals shares in Q1 2026, an estimated $1.6M.
  • Atea Pharmaceuticals made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3922 holding.
  • Millennium Management first reported a position in Atea Pharmaceuticals in Q1 2021 and has held it in 14 quarters since.
  • Millennium Management's Atea Pharmaceuticals position peaked at $4.05M in Q3 2021.
  • 127 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.